Covance Co-Locates Facility for Increased Patient Exposure

Article

Applied Clinical Trials

LabCorp® announced that Covance Drug Development has relocated its clinical research unit in Dallas, TX, to a new, fit-for-purpose clinical research facility.

LabCorp® announced that Covance Drug Development has relocated its clinical research unit  in Dallas, TX, to a new, fit-for-purpose clinical research facility.  This unit opened earlier this month and has expanded from 72 to 100 medical beds. In addition, a LabCorp patient service center will be co-located in the CRU, at which patients will have an opportunity to learn more about volunteering and participating in early stage clinical trials.

 

Read the full release here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.